Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.80279 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.64775 | 61 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.661 | 61 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.56438 | 60 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.57215 | 60 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.91508 | 64 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.9006 | 64 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.65656 | 61 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.59731 | 60 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.59992 | 60 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.67705 | 62 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.64685 | 61 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.12295 | 68 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.68324 | 62 |